Fintel reports that on October 31, 2025, Stifel maintained coverage of DXC Technology (NYSE:DXC) with a Hold recommendation.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Dxc Technology Company ( ($DXC) ) has released its Q2 earnings. Here is a breakdown of the information Dxc Technology Company presented to its ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

Loeb, Affiliated Investigator Angela Parcesepe, Distinguished Professor Denis Nash, and colleagues from the CUNY Institute ...

This is read by an automated voice. Please report any issues or inconsistencies here. Revolutionizing regulatory compliance with AI-driven insights, regulatory monitoring and regulatory news to ...

Q. I am interested in an electric car and the Tesla Model 3 looks good, but somehow Elon and politics are entering into my decision to buy or lease a Tesla. I am generally not political, but it may be ...

The most recent recommendations from the Centers for Disease Control and Prevention on COVID-19 vaccines call for “vaccination based on shared clinical decision-making,” according to a news release ...

Share on Pinterest A new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty Images Researchers say ...

DXC Technology Company (NYSE:DXC) is one of the oversold tech stocks to invest in. On September 17, DXC Technology announced the launch of a new AI Center of Competence in Warsaw, Poland. This center ...